Methods: Consecutive first - ever stroke or
TIA patients (n = 266) from the Tel Aviv Acute Brain Stroke Cohort (TABASCO) study were enrolled.
About 14 percent of
all TIA patients showed significantly reduced mental quality of life and 6.5 percent had reduced physical quality of life.
«We found one in three
TIA patients develop PTSD,» said Kathrin Utz, Ph.D., a study author and post-doctoral researcher in the Department of Neurology at the University of Erlangen - Nuremberg in Germany.
After examining data from 108
TIA patients with no prior history of stroke and reviewing participants» answers to a series of questionnaires that evaluated their mental state, German and British researchers found:
Not exact matches
Patients» fear of having a stroke and poor coping behaviors after a
TIA may be partially to blame for them developing PTSD.
«
Patients who use certain types of coping strategies, such as denying the problem, blaming themselves for any difficulties or turning to drugs for comfort, face a greater risk of developing PTSD after
TIA,» Utz said.
Utz suggests providing
patients better risk counselling and more positive adaptive strategies to cope with
TIA.
The study is the first to analyze whether a
TIA and the knowledge of an increased risk for stroke can lead
patients to develop psychiatric problems.
However, what we do know at this stage is that younger
patients and
patients who in general find it difficult to cope with stress are more likely to develop psychological problems following a
TIA.»
A study called Stroke Warning Information and Faster Treatment (SWIFT) compared interactive intervention with enhanced educational materials on recurrent stroke arrival times in
patients with mild stroke or transient ischemic attack (
TIA).
The Chinese trial, called CHANCE (Clopidogrel in High - risk
Patients with Acute Non-disabling Cerebrovascular Events), is nearly identical to a National Institutes of Health - sponsored trial that is already enrolling patients in the United States, including at UCSF, called POINT (Platelet - Oriented Inhibition in New TIA and Minor Ischemic
Patients with Acute Non-disabling Cerebrovascular Events), is nearly identical to a National Institutes of Health - sponsored trial that is already enrolling
patients in the United States, including at UCSF, called POINT (Platelet - Oriented Inhibition in New TIA and Minor Ischemic
patients in the United States, including at UCSF, called POINT (Platelet - Oriented Inhibition in New
TIA and Minor Ischemic Stroke).
But in
patients with
TIAs and many minor strokes, the clot quickly goes away, usually in a few minutes, due to the natural mechanisms in the human body that are designed to deal with such clots.
Many studies show an elevated risk over time, although most have included
patients with complications in the early 90 - day high - risk period and not survivors without complications in the period following stroke or transient ischemic attack (
TIA).
Additional options for long - term risk reduction could include tailoring existing cardiac rehabilitation programs for stroke survivors, following
patients for years rather than months after their stroke or
TIA, and embedding long - term management into primary care practices.
In
patients with stroke or transient ischemic attack (
TIA) of unknown etiology, which accounts for one - third of these
patients, the deCODE AF ™ test may determine which
patients are at greater risk of AF and therefore may most likely benefit from extended cardiac monitoring for AF.
If you are taking any of these medications because of your
TIA, expect that some burial insurance companies will view you as a mini stroke
patient.
A mini-stroke is also known as a
TIA (Transient Ischemic Attack) and presents the same symptoms as a full stroke, but the
patient doesn't experience any permanent neurological damage.